// App-Quantinova.ai

EP40 : Real world efficacy of secukinumab: a single centre experience

Researchers

Presenter

  • Tim Blake

Principal Investigators

  • Nicola J Gullick

Medical Centers

  • University Hospital Coventry & Warwickshire, Rheumatology, Coventry, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • Ankylosing spondylitis

  • Psoriasis

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • secukinumab

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved